2023-04-012024-03-312024-03-31false09379070BLUELINE HEALTHCARE SOLUTIONS LTD2024-12-31falseiso4217:GBPxbrli:pure093790702023-04-01093790702024-03-31093790702023-04-012024-03-31093790702022-04-01093790702023-03-31093790702022-04-012023-03-3109379070bus:SmallEntities2023-04-012024-03-3109379070bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3109379070bus:AbridgedAccounts2023-04-012024-03-3109379070bus:PrivateLimitedCompanyLtd2023-04-012024-03-3109379070core:WithinOneYear2024-03-3109379070core:AfterOneYear2024-03-3109379070core:WithinOneYear2023-03-3109379070core:AfterOneYear2023-03-3109379070core:ShareCapital2024-03-3109379070core:SharePremium2024-03-3109379070core:RevaluationReserve2024-03-3109379070core:OtherReservesSubtotal2024-03-3109379070core:RetainedEarningsAccumulatedLosses2024-03-3109379070core:ShareCapital2023-03-3109379070core:SharePremium2023-03-3109379070core:RevaluationReserve2023-03-3109379070core:OtherReservesSubtotal2023-03-3109379070core:RetainedEarningsAccumulatedLosses2023-03-3109379070core:LandBuildings2024-03-3109379070core:PlantMachinery2024-03-3109379070core:Vehicles2024-03-3109379070core:FurnitureFittings2024-03-3109379070core:OfficeEquipment2024-03-3109379070core:NetGoodwill2024-03-3109379070core:IntangibleAssetsOtherThanGoodwill2024-03-3109379070core:ListedExchangeTraded2024-03-3109379070core:UnlistedNon-exchangeTraded2024-03-3109379070core:LandBuildings2023-03-3109379070core:PlantMachinery2023-03-3109379070core:Vehicles2023-03-3109379070core:FurnitureFittings2023-03-3109379070core:OfficeEquipment2023-03-3109379070core:NetGoodwill2023-03-3109379070core:IntangibleAssetsOtherThanGoodwill2023-03-3109379070core:ListedExchangeTraded2023-03-3109379070core:UnlistedNon-exchangeTraded2023-03-3109379070core:LandBuildings2023-04-012024-03-3109379070core:PlantMachinery2023-04-012024-03-3109379070core:Vehicles2023-04-012024-03-3109379070core:FurnitureFittings2023-04-012024-03-3109379070core:OfficeEquipment2023-04-012024-03-3109379070core:NetGoodwill2023-04-012024-03-3109379070core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109379070core:ListedExchangeTraded2023-04-012024-03-3109379070core:UnlistedNon-exchangeTraded2023-04-012024-03-3109379070core:MoreThanFiveYears2023-04-012024-03-3109379070core:Non-currentFinancialInstruments2024-03-3109379070core:Non-currentFinancialInstruments2023-03-3109379070dpl:CostSales2023-04-012024-03-3109379070dpl:DistributionCosts2023-04-012024-03-3109379070core:LandBuildings2023-04-012024-03-3109379070core:PlantMachinery2023-04-012024-03-3109379070core:Vehicles2023-04-012024-03-3109379070core:FurnitureFittings2023-04-012024-03-3109379070core:OfficeEquipment2023-04-012024-03-3109379070dpl:AdministrativeExpenses2023-04-012024-03-3109379070core:NetGoodwill2023-04-012024-03-3109379070core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109379070dpl:GroupUndertakings2023-04-012024-03-3109379070dpl:ParticipatingInterests2023-04-012024-03-3109379070dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109379070core:ListedExchangeTraded2023-04-012024-03-3109379070dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109379070core:UnlistedNon-exchangeTraded2023-04-012024-03-3109379070dpl:CostSales2022-04-012023-03-3109379070dpl:DistributionCosts2022-04-012023-03-3109379070core:LandBuildings2022-04-012023-03-3109379070core:PlantMachinery2022-04-012023-03-3109379070core:Vehicles2022-04-012023-03-3109379070core:FurnitureFittings2022-04-012023-03-3109379070core:OfficeEquipment2022-04-012023-03-3109379070dpl:AdministrativeExpenses2022-04-012023-03-3109379070core:NetGoodwill2022-04-012023-03-3109379070core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3109379070dpl:GroupUndertakings2022-04-012023-03-3109379070dpl:ParticipatingInterests2022-04-012023-03-3109379070dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3109379070core:ListedExchangeTraded2022-04-012023-03-3109379070dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3109379070core:UnlistedNon-exchangeTraded2022-04-012023-03-3109379070core:NetGoodwill2024-03-3109379070core:IntangibleAssetsOtherThanGoodwill2024-03-3109379070core:LandBuildings2024-03-3109379070core:PlantMachinery2024-03-3109379070core:Vehicles2024-03-3109379070core:FurnitureFittings2024-03-3109379070core:OfficeEquipment2024-03-3109379070core:AfterOneYear2024-03-3109379070core:WithinOneYear2024-03-3109379070core:ListedExchangeTraded2024-03-3109379070core:UnlistedNon-exchangeTraded2024-03-3109379070core:ShareCapital2024-03-3109379070core:SharePremium2024-03-3109379070core:RevaluationReserve2024-03-3109379070core:OtherReservesSubtotal2024-03-3109379070core:RetainedEarningsAccumulatedLosses2024-03-3109379070core:NetGoodwill2023-03-3109379070core:IntangibleAssetsOtherThanGoodwill2023-03-3109379070core:LandBuildings2023-03-3109379070core:PlantMachinery2023-03-3109379070core:Vehicles2023-03-3109379070core:FurnitureFittings2023-03-3109379070core:OfficeEquipment2023-03-3109379070core:AfterOneYear2023-03-3109379070core:WithinOneYear2023-03-3109379070core:ListedExchangeTraded2023-03-3109379070core:UnlistedNon-exchangeTraded2023-03-3109379070core:ShareCapital2023-03-3109379070core:SharePremium2023-03-3109379070core:RevaluationReserve2023-03-3109379070core:OtherReservesSubtotal2023-03-3109379070core:RetainedEarningsAccumulatedLosses2023-03-3109379070core:NetGoodwill2022-04-0109379070core:IntangibleAssetsOtherThanGoodwill2022-04-0109379070core:LandBuildings2022-04-0109379070core:PlantMachinery2022-04-0109379070core:Vehicles2022-04-0109379070core:FurnitureFittings2022-04-0109379070core:OfficeEquipment2022-04-0109379070core:AfterOneYear2022-04-0109379070core:WithinOneYear2022-04-0109379070core:ListedExchangeTraded2022-04-0109379070core:UnlistedNon-exchangeTraded2022-04-0109379070core:ShareCapital2022-04-0109379070core:SharePremium2022-04-0109379070core:RevaluationReserve2022-04-0109379070core:OtherReservesSubtotal2022-04-0109379070core:RetainedEarningsAccumulatedLosses2022-04-0109379070core:AfterOneYear2023-04-012024-03-3109379070core:WithinOneYear2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3109379070core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109379070core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109379070core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3109379070core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3109379070core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3109379070bus:Director12023-04-012024-03-31

BLUELINE HEALTHCARE SOLUTIONS LTD

Registered Number
09379070
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

BLUELINE HEALTHCARE SOLUTIONS LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

WINSOR, Shamiso

Registered Address

Redwood House Brotherswood Court
Almondsbury
Bristol
BS32 4QW

Registered Number

09379070 (England and Wales)
BLUELINE HEALTHCARE SOLUTIONS LTD
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets33,1714,733
3,1714,733
Current assets
Debtors-57,561
Cash at bank and on hand119,350160
119,35057,721
Creditors amounts falling due within one year(90,982)(33,426)
Net current assets (liabilities)28,36824,295
Total assets less current liabilities31,53929,028
Creditors amounts falling due after one year(3,872)(14,196)
Net assets27,66714,832
Capital and reserves
Called up share capital22
Profit and loss account27,66514,830
Shareholders' funds27,66714,832
The financial statements were approved and authorised for issue by the Director on 31 December 2024, and are signed on its behalf by:
WINSOR, Shamiso
Director
Registered Company No. 09379070
BLUELINE HEALTHCARE SOLUTIONS LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20242023
Average number of employees during the year82
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 238,415
At 31 March 248,415
Depreciation and impairment
At 01 April 233,682
Charge for year1,562
At 31 March 245,244
Net book value
At 31 March 243,171
At 31 March 234,733